Norris Medicines Limited

BOM-524414
Bombay Stock Exchange NYSE
Pharmaceutical Preparations
Global Rank
#45707
Country Rank
n/a
Market Cap
2.28 M
Price
0.24
Change (%)
1.91%
Volume
889

Norris Medicines Limited's latest marketcap:

2.28 M

As of 06/04/2025, Norris Medicines Limited's market capitalization has reached $2.28 M. According to our data, Norris Medicines Limited is the 45707th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 2.28 M
Revenue (ttm) 686,147.46
Net Income (ttm) -144,366.75
Shares Out 10 M
EPS (ttm) -0.01
Forward PE 0.00
Ex-Dividend Date n/a
Earnings Date 05/26/2025
Market Cap Chart
Data Updated: 06/04/2025

Norris Medicines Limited's yearly market capitalization.

Norris Medicines Limited has seen its market value grow from ₹62 M to ₹195.01 M since 2020, representing a total increase of 214.52% and an annual compound growth rate (CAGR) of 29.56%.
Date Market Cap Change (%)
06/04/2025 ₹195.01 M 21.38%
12/31/2024 ₹173.51 M 27.48%
12/29/2023 ₹136.11 M -1.95%
12/30/2022 ₹138.81 M 29.72%
12/31/2021 ₹107.01 M 72.58%
12/31/2020 ₹62 M

Company Profile

About Norris Medicines Limited

Norris Medicines Limited is a leading pharmaceutical manufacturer based in Ankleshwar, India. Established in 1990, the company specializes in producing a wide range of pharmaceutical formulations.

Product Portfolio

The company offers diverse pharmaceutical products across multiple therapeutic areas, including:

  • Antibiotics
  • Anti-inflammatory & pain management
  • Analgesics
  • Gastrointestinal treatments
  • Dermatological solutions
  • Nutritional supplements
  • Anti-malarial medications
  • Anti-emetics
  • Cough & cold remedies
  • Dental care products
  • Diabetic treatments
  • Cardiac medications

Formulations & Services

Norris Medicines provides its products in various forms, such as:

  • Tablets
  • Capsules
  • Liquid orals
  • Topical ointments

The company also offers contract manufacturing and loan license manufacturing services to pharmaceutical businesses.

Global Reach

In addition to serving the domestic market, Norris Medicines exports its products to:

  • European countries
  • Middle East
  • Far East
  • African countries

Frequently Asked Questions

MarketCapWatch.com ranks all listed companies worldwide, providing unique insights into market capitalization across industries. As one of the most comprehensive ranking platforms, it covers companies of all sizes and sectors.

Ranking
Community

Copyright © 2025. All rights reserved

Important Disclaimer: All content provided on this website, including hyperlinked pages, related applications, forums, blogs, social media accounts, and other platforms ("the Site"), is for general informational purposes only and sourced from third-party providers. We make no guarantees regarding the accuracy, completeness, or timeliness of the content.

None of the information presented constitutes financial, legal, or professional advice. Users should conduct their own research, evaluation, and verification before making any decisions. Investing and trading carry significant risks that may lead to substantial losses. Therefore, we strongly recommend consulting a qualified financial advisor before taking any action.